MTOR and familial mitral valve prolapse: Identification of mTOR as a therapeutic target for preventing the progression of myxomatous mitral valve disease in a mouse model and evidence of mTOR activation in human specimens of sporadic MVP hold important translational implication given the availability of several mTOR inhibitors approved for clinical use.